Dr Phil Choi

Professional Details

Current Placements

Published ITP Research

• Choi PY, Merriman E, Bennett A, Enjeti AK, Tan CW, Goncalves I, et al. Updated treatment options for immune thrombocytopenia. Internal Medicine Journal. 2023;In press.
• Choi PY, Merriman E, Bennett A, Enjeti AK, Tan CW, Goncalves I, et al. Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand. Med J Aust. 2022;216(1):43-52.
• Choi PY, Hsu D, Tran HA, Tan CW, Enjeti A, Chen VMY, et al. Immune thrombocytopenia and COVID-19 vaccination: Outcomes and comparisons to prepandemic patients. Res Pract Thromb Haemost. 2023;7(1):100009.
• Kuter DJ, Efraim M, Mayer J, Trněný M, McDonald V, Bird R, et al. Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia. New England Journal of Medicine. 2022;386(15):1421-31.
• Choi PY, Hsu D, Tran HA, Tan CW, Enjeti A, Chen VMY, et al. Immune thrombocytopenia following vaccination during the COVID-19 pandemic. Haematologica. 2022;107(5):1193-6.
• Aitken L, Patel R, D'Rozario J, Choi P. Alemtuzumab-induced red cell aplasia and other immune cytopenias: not so ‘pure’. Immunotherapy. 2022;14(2):95-9.
• Chen VM, Curnow JL, Tran HA, Choi PY. Australian and New Zealand approach to diagnosis and management of vaccine-induced immune thrombosis and thrombocytopenia. Med J Aust. 2021;215(6):245-9 e1
• Choi PY, Gordon JE, Harvey M, Chong BH. Presentation and outcome of idiopathic thrombocytopenic purpura in a single Australian centre. Intern Med J. 2012;42(7):841-5.
• Choi PY, Roncolato F, Badoux X, Ramanathan S, Ho SJ, Chong BH. A novel triple therapy for ITP using high dose dexamethasone, low dose rituximab and cyclosporine (TT4). Blood. 2015;126(4):500-3.
• Iraqi M, Perdomo J, Yan F, Choi PY, Chong BH. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro. Haematologica. 2015;100(5):623-32.